Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The National Cancer Institute (NCI) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 11 clinical trials at NIH that match your search criteria

Cancer by body location/system: Breast Cancer

Trial and Protocol Number Breast Cancer	Principal Investigator	Referral Contact
Phase I/II Study of Metastatic Cancer that Expresses HER-2 Using Lymphodepleting Conditioning Followed by Infusion of Anti-HER-2 Gene Engineered Lymphocytes NCI-09-C-0041	Steven A. Rosenberg 1-866-820-4505 (Toll Free)	Linda Williams 1-866-820-4505 (Toll Free) ncisbirc@mail.nih.gov
A Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in BRCA 1/2 Mutation Carriers and Familial Breast and Ovarian Cancer NCI-08-C-0092	Elise C. Kohn 301-402-2726	Laura D. Otten 301-451-1228 1-866-611-6310 (Toll Free) ottenl@mail.nih.gov
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer NCI-07-C-0123	Jennifer Eng-Wong 301-496-5320	Guinevere Chun 301-451-7868 gchun@mail.nih.gov
A Phase 0 Trial of [111] Indium CHX-A" DTPA Trastuzumab Imaging in Cancer NCI-07-C-0101	Peter Choyke 301-451-4220	Yolanda McKinney 301-443-1718 ymckinney@mail.nih.gov
A Phase I Trial of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine in Advanced Malignancies NCI-06-C-0221	James Doroshow 301-496-4291	Janelle Bingham 301-435-2715 jbingham@mail.nih.gov
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Patients With Metastatic Breast Cancer NCI-05-C-0229	James L. Gulley 301-435-2956	Laura D. Otten 301-451-1228 1-866-611-6310 (Toll Free) ottenl@mail.nih.gov
Phase I Trial of T Cell Exchange With Th2/Tc2 Cells for Allogenic Stem Cell Transplantation After Reduced Intensity Conditioning for Metastatic Breast Cancer NCI-04-C-0131	Michael Bishop 301-435-2764	Mike Krumlauf 301-594-2056 krumlaum@mail.nih.gov
A Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients With Metastatic Breast Cancer Untreated With Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion NCI-03-C-0040	Claude Sportés 301-435-5280	Mike Krumlauf 301-594-2056 krumlaum@mail.nih.gov
Clinical, Genetic, Behavioral, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer NCI-02-C-0212	Phuong Mai 301-496-9928	Stephanie Steinbart 1-800-518-8474 (Toll Free)
Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile NCI-02-C-0077	David N. Danforth 301-496-1533
A Phase I Investigation of IL-12/Pulse IL-2 in Adults With Advanced Solid Tumors NCI-00-C-0121	John E. Janik 301-402-2913	Guinevere Chun 301-451-7868 gchun@mail.nih.gov

If there are no studies listed for your specific disease type, please search under:

Solid Tumor (advanced malignancy)